Pharmaids Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 524572 | NSE: | Pharmaceuticals & Drugs | Small Cap

Pharmaids Pharma Share Price

67.13 3.19 4.99%
as on 21-Feb'25 16:59

DeciZen - make an informed investing decision on Pharmaids Pharma

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Pharmaids Pharmaceuticals stock performance -
67.13 8.0014.00% past year

Price Chart, Live Stock Chart, Technical Chart of
P/E Ratio (SA):
0.00
Market Cap:
236.8 Cr.
52-wk low:
31.9
52-wk high:
87.5

Is Pharmaids Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Pharmaids Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Pharmaids Pharmaceuticals Ltd is a below average quality company.

2. Is Pharmaids Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Pharmaids Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Pharmaids Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Pharmaids Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Pharmaids Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Pharmaids Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE %
-5%-21.2%7.6%-29.7%-3%-4.5%1%1.7%-64%-10.9%-
Value Creation
Index
-1.4-2.5-0.5-3.1-1.2-1.3-0.9-0.9-5.6-1.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales
1.71.71.20.50.608.63.9002
Sales YoY Gr.
--2.9%-28.6%-62.5%24.4%-100%NA-53.9%-100%NA-
Adj EPS
-0.2-1.2-0.8-1.1-0.200.10.1-3.5-1.4-1.8
YoY Gr.
-NANANANANA200%55.6%-2614.3%NA-
BVPS (₹)
5.13.94.33.18.28.28.38.410.220.219
Adj Net
Profit
-0.1-0.4-0.3-0.4-0.200.10.2-7.6-5-6
Cash Flow from Ops.
0.200.3-0.2-0.1-0.80.4-0.3-4-3.4-
Debt/CF from Ops.
1.428.60000000-3.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -36.3%-44.3%-84.8%NA
Adj EPS NANA-349.6%NA
BVPS16.5%19.8%34.4%96.8%
Share Price 34.6% 68.5% 72.5% 19.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-3.7-26.2-18.5-31.2-3.80.41.11.7-48.6-10.6-9.4
Op. Profit
Mgn %
-5.3-20.5-28.6-86-18.101.33.50-22912.2-324.3
Net Profit
Mgn %
-3.8-23.6-21.1-85.9-31.601.13.70-17806.3-292.1
Debt to
Equity
0.20.400000000.2-
Working Cap
Days
4243854701,0032,9550334831071,18815,403
Cash Conv.
Cycle
2052092143593450312014,85011,814

Recent Performance Summary

Sales growth is good in last 4 quarters at 1487.50%

Return on Equity is Poor

Sales growth has been subdued in last 3 years -84.80%

Latest Financials - Pharmaids Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) -1.8 -3.5
TTM Sales (₹ Cr.) 2.2 20.4
BVPS (₹.) 19 18.2
Reserves (₹ Cr.) 32 29
P/BV 3.54 3.69
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 31.90 / 87.46
All Time Low / High (₹) 1.00 / 87.46
Market Cap (₹ Cr.) 237
Equity (₹ Cr.) 35.3
Face Value (₹) 10
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 184 -15.4163 -9.3208 14.8318 90.9
Adj EPS (₹) 2.3 -21.62.2 -14.23.4 21.75.7 154.9
Op. Profit Mgn % 28.85 -351 bps27.17 -567 bps33.37 -116 bps38.95 622 bps
Net Profit Mgn % 21.56 -177 bps23.19 -138 bps28.02 162 bps31.09 775 bps

Management X-Ray of Pharmaids Pharma:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:5.22%Institutions:0%Non-Institutions:94.78%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240%5%10%15%20%25%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Pharmaids Pharma

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Pharmaids Pharma

Adj EPS (Rs.)

Price Chart, Live Stock Chart, Technical Chart of

Sales (Cr.)

Price Chart, Live Stock Chart, Technical Chart of

ROE (%)

Price Chart, Live Stock Chart, Technical Chart of

ROCE (%)

Price Chart, Live Stock Chart, Technical Chart of
Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales2210109400
Operating Expenses 22211084106
Manufacturing Costs0000000000
Material Costs1110008410
Employee Cost 0000000012
Other Costs 1110000084
Operating Profit 00000000-10-6
Operating Profit Margin (%) -5.3%-20.5%-28.6%-86.0%-18.1%-1.3%3.5%--22,912.2%
Other Income 0000000001
Interest 0000000000
Depreciation 0000000000
Exceptional Items 0010000000
Profit Before Tax 00000000-10-6
Tax 00000000-2-1
Profit After Tax 00000000-8-5
PAT Margin (%) -3.8%-23.6%9.1%-85.9%-31.6%-1.1%3.7%--17,805.0%
Adjusted EPS (₹)-0.2-1.20.3-1.2-0.20.00.10.1-3.5-1.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 211188992271
Share Capital 3333101010102135
Reserves -2-2-2-2-2-2-2-2136
Minority Interest0000000000
Debt00000000013
Long Term Debt00000000013
Short Term Debt0000000000
Trade Payables0000001220
Others Liabilities 00000000-2-2
Total Liabilities 3221989112281

Fixed Assets

Gross Block22000111017
Accumulated Depreciation2200000000
Net Fixed Assets00000000017
CWIP 0000000022
Investments 00000000353
Inventories0000000100
Trade Receivables1111100120
Cash Equivalents 00100000132
Others Assets0001787827
Total Assets 3221989112281

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 00000-100-4-3
PBT 00000000-10-6
Adjustment 0000000003
Changes in Working Capital 00000-00-060
Tax Paid 0000000000
Cash Flow From Investing Activity 00000100-5-73
Capex 00000000-2-16
Net Investments 0000000000
Others 00000100-3-56
Cash Flow From Financing Activity 000000002166
Net Proceeds from Shares 000000002154
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 00000000012
Net Cash Flow 0000000012-10
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-3.71-26.217.99-31.24-3.760.41.11.69-49.34-10.64
ROCE (%)-4.99-21.197.61-29.73-3.02-4.451.041.66-63.95-10.87
Asset Turnover Ratio0.640.70.560.270.1101.010.400
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days2502372835304570127500
Inventory Days606381000165803,011
Payable Days1651352422341760111438610

Pharmaids Pharmaceuticals Ltd Stock News

Pharmaids Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Pharmaids Pharma on 21-Feb-2025 16:59 is ₹67.13.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Feb-2025 16:59 the market cap of Pharmaids Pharma stood at ₹236.8.
The latest P/E ratio of Pharmaids Pharma as of 21-Feb-2025 16:59 is 0.00.
The latest P/B ratio of Pharmaids Pharma as of 21-Feb-2025 16:59 is 3.54.
The 52-week high of Pharmaids Pharma is ₹87.46 and the 52-week low is ₹31.90.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Pharmaids Pharma is ₹2.21 ( Cr.) .

About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Limited Incorporated in the year 1989 at Hyderabad (Telangana, India). The company is suppliers of Quality Grade range of Specialty chemicals, Skin care, Hospital care and Generic products in the areas of Orthopedic, Neuro and Gastro etc. Its technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygienic standards. Its professionals strive to offer best quality and high purity to attain maximum client's satisfaction. The company’s offered product range is highly acknowledged in the market for its precise composition long shelf life, hygienic processing techniques, premium quality and high purity.

Business area of the company

The Company is engaged in the business of Trading and Manufacturing of Generics, Bulk Drugs and Intermediaries, etc.

Products

  • Speciality Chemicals
  • Skin Care Products
  • Hospital Care Products
  • Generics
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on